SABRE: A multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis

Thorax

Volumn 69, Issue 12, 2014, Pages 1105-1112

  Everard, Mark L ^a   Hind, Daniel ^b   Ugonna, Kelechi ^c   Freeman, Jennifer ^d   Bradburn, Mike ^b   Cooper, Cindy L ^b   Cross, Elizabeth ^b   Maguire, Chin ^b   Cantrill, Hannah ^b   Alexander, John ^e   McNamara, Paul S ^f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; SODIUM CHLORIDE;

ARTICLE; BRADYCARDIA; BRONCHIOLITIS; CHILD CARE; CHILD HOSPITALIZATION; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INFANT; INTERMETHOD COMPARISON; LENGTH OF STAY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEBULIZATION; OPEN STUDY; OUTCOME ASSESSMENT; OXYGEN DESATURATION; OXYGEN THERAPY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION DISORDER; UNITED KINGDOM; ACUTE DISEASE; BRONCHIOLITIS, VIRAL; CLINICAL TRIAL; HOSPITALIZATION; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; NEBULIZER; NEWBORN; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, INHALATION; BRONCHIOLITIS, VIRAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; NEBULIZERS AND VAPORIZERS; OXYGEN INHALATION THERAPY; SALINE SOLUTION, HYPERTONIC; TREATMENT OUTCOME;

EID: 84919721616     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205953     Document Type: Article

References (33)

1. Everard M. Respiratory syncytial virus bronchiolitis and pneumonia. In: Taussig L, Landau L, eds. Paediatric Respiratory Medicine. St Louis: Mosby, 2009:491-500.
2. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98.
3. Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 2010;125:342-9.
4. Øymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med 2014;22:23.
5. Martin AJ, Gardner PS, Mcquillin J. Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in North-East England. Lancet 1978;312:1035-8.
6. Centers for Disease Control and Prevention (CDC). Respiratory syncytial virus activity - United States, July 2008-December 2009. MMWR Morb MortalWkly Rep. 2010;59:230-3. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5908a4.htm (accessed 5 Mar 2014).
7. Everard ML. Acute bronchiolitis and croup. Pediatr Clin North Am 2009;56:119-33, x-xi.
8. Scottish Intercollegiate Guidelines Network SIGN. Bronchiolitis in children - a national clinical guideline. 2006. http://www.sign.ac.uk/pdf/sign91.pdf (accessed 5 Mar 2014).
9. Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-93.
10. Reynolds E, Cook C. The treatment of bronchiolitis. J Pediatr 1963;63:1205-7.
11. Hubble D, Osborn GR. Acute bronchiolitis in children. Br Med J 1941;1:107-26.1.
12. Fleming DM, Pannell RS, Cross KW. Mortality in children from in fluenza and respiratory syncytial virus. J Epidemiol Community Health 2005;59:586-90.
13. Panickar JR, Dodd SR, Smyth RL, et al. Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000. Thorax 2005;60:1035-8.
14. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2001;375:1545-55. http://www.sciencedirect.com/science/article/pii/S0140673610602061
15. Hospital Episode Statistics 2009/10. http://www.hscic.gov.uk/pubs/hes0910 (accessed 1 Apr 2014).
16. Pelletier AJ, Mansbach JM, Camargo CA. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006;118:2418-23.
17. Behrendt CE, Decker MD, Burch DJ, et al. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998;157:215-20.
18. Coon JT, Martin A, Abdul-Rahman A-K, et al. Interventions to reduce acute paediatric hospital admissions: a systematic review. Arch Dis Child 2012;97:304-11.
19. Anderson LJ. Respiratory syncytial virus vaccine development. Semin Immunol 2013;25:160-71.
20. Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane database Syst Rev 2013;7: CD006458. http://www.ncbi.nlm.nih.gov/pubmed/23900970 (accessed 27 Jan 2014).
21. Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol 2010;45:36-40.
22. Everard ML, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994;71:428-32.
23. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ Br Med J 2010;340:c869.
24. The SABRE Team. HTA-09/91/22: SABRE (hypertonic Saline in Acute Bronchiolitis Rct and Economic evaluation), Protocol Version 0.8, 04 Jun 2013. http://www.nets.nihr.ac.uk/projects/hta/099122 (accessed 29 May 2014).
25. Raat H, Landgraf J, Oostenbrink R, et al. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res 2007;16:445-60.
26. Elashoff J, Reedy T. Two-stage clinical trial stopping rules. Biometrics 1984;40:791-5.
27. Therneau TM, Grambsch P. Modeling survival data: extending the cox model. New York: Springer-Verlag, 2000.
28. Boogaard R, de Jongste JC, Merkus PJFM. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature. Pediatr Pulmonol 2007;42:989-1001.
29. Everard ML. Inhaler devices in infants and children: challenges and solutions. J Aerosol Med 2004;17:186-95.
30. Sharma BS, Gupta MK, Rafik SP. Hypertonic (3%) saline vs 0.9% saline nebulization for acute viral bronchiolitis: a randomized controlled trial. Indian Pediatr 2013;50:743-7.
31. Teunissen J, Hochs A, Vaessen-Verberne AAP, et al. Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis. ERS Congr Abstr 2011:293-4. http://www.ers-education.org/ersMade/abstract-print-11/files/Abstract-book-2011.pdf (accessed 15 Apr 2014).
32. Elphick HE, Sherlock P, Foxall G, et al. Survey of respiratory sounds in infants. Arch Dis Child 2001;84:35-9.
33. Elphick HE, Lancaster GA, Solis A, et al. Validity and reliability of acoustic analysis of respiratory sounds in infants. Arch Dis Child 2004;89:1059-63.